Skip to main content
Year archive

GENETIC SIGNATURES LIMITED — 2023 filings

All 36 regulatory filings released by GENETIC SIGNATURES LIMITED (GSS) in 2023, sourced directly from the official regulator.

36 Filings
2023 Period
2023 filings (36)
Filing Released Lang
Genetic Signatures Successfully Completes Placement 2 pages 397.6KB
Regulatory Filings
2023-12-28 English
Application for quotation of securities - GSS 6 pages 27.9KB
Share Issue/Capital Change
2023-12-28 English
Cleansing Notice 2 pages 273.6KB
Regulatory Filings
2023-12-28 English
Notification regarding unquoted securities - GSS 6 pages 28.7KB
Share Issue/Capital Change
2023-12-28 English
Notification of cessation of securities - GSS 4 pages 23.9KB
Regulatory Filings
2023-12-28 English
Change of Director's Interest Notice 2 pages 245.1KB
Director's Dealing
2023-12-28 English
Genetic Signatures Announces $15.9m Capital Raising 5 pages 946.3KB
Regulatory Filings
2023-12-20 English
Capital Raising Presentation 42 pages 4.3MB
Capital/Financing Update
2023-12-20 English
Proposed issue of securities - GSS 11 pages 43.1KB
Capital/Financing Update
2023-12-20 English
Cleansing Notice 3 pages 590.2KB
Regulatory Filings
2023-12-20 English
Trading Halt 2 pages 236.2KB
Regulatory Filings
2023-12-18 English
$6.9m R&D tax incentive received 1 page 211.1KB
Report Publication Announcement
2023-12-18 English
Genetic Signatures Appoints Non-Executive Director 1
Regulatory Filings
2023-12-03 English
Initial Director's Interest Notice 2 pages 203.0KB
Director's Dealing
2023-12-03 English
2023 AGM Chairman's Address and CEO Presentation 20 pages 2.8MB
AGM Information
2023-11-28 English
AGM Results of Meeting 2 pages 78.6KB
Declaration of Voting Results & Voting Rights Announcements
2023-11-28 English
Quarterly update and Appendix 4C 9 pages 415.1KB
Interim / Quarterly Report
2023-10-29 English
2023 Notice of Annual General Meeting/Proxy Form 16 pages 3.0MB
Regulatory Filings
2023-10-26 English
Investor Presentation - US Commercial Launch 34 pages 8.4MB
Investor Presentation
2023-09-18 English
Change in substantial holding 7 pages 906.4KB
Major Shareholding Notification
2023-09-14 English
FDA 510(k) for Gastrointestinal Parasite Kit Submitted 3 pages 242.8KB
Regulatory Filings
2023-09-03 English
510(k) Filing in Preparation for US Commercial Launch 26 pages 2.7MB
Interim / Quarterly Report
2023-09-03 English
Investor Webinar - FY2023 Results and US FDA 510(k) 1
Investor Presentation
2023-09-03 English
Appendix 4E and Annual Report 92 pages 4.4MB
Annual Report
2023-08-30 English
Appendix 4G and Corporate Governance Statement 21 pages 573.3KB
Governance Information
2023-08-30 English
Influenza B Detection Expected to Impact on Quarter Sales 1
Capital/Financing Update
2023-08-24 English
Quarterly update and Appendix 4C 11 pages 418.1KB
Interim / Quarterly Report
2023-07-30 English
CFO/Company Secretary Appointment 1 page 54.2KB
Board/Management Information
2023-06-15 English
Quarterly update and Appendix 4C 9 pages 1.2MB
Interim / Quarterly Report
2023-04-27 English
Company Secretary/CFO Appointment/Resignation 1 pag
Board/Management Information
2023-03-20 English
Investor Presentation 18 pages 3.2MB
Interim / Quarterly Report
2023-03-13 English
Change of Director's Interest Notice 2 pages 263.6KB
Director's Dealing
2023-02-28 English
Half Yearly Report and Accounts 22 pages 1.4MB
Interim / Quarterly Report
2023-02-21 English
Investor presentation 16 pages 2.5MB
Investor Presentation
2023-02-01 English
Quarterly update and Appendix 4C 9 pages 264.1KB
Interim / Quarterly Report
2023-01-29 English
Notification of cessation of securities - GSS 4 pages 24.8KB
Regulatory Filings
2023-01-10 English